Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
p53-dependent SIRT6 expression protects Aβ42-induced DNA damage
View through CrossRef
AbstractAlzheimer’s disease (AD) is the most common type of dementia and age-related neurodegenerative disease. Elucidating the cellular changes that occur during ageing is an important step towards understanding the pathogenesis and progression of neurodegenerative disorders. SIRT6 is a member of the mammalian sirtuin family of anti-aging genes. However, the relationship between SIRT6 and AD has not yet been elucidated. Here, we report that SIRT6 protein expression levels are reduced in the brains of both the 5XFAD AD mouse model and AD patients. Aβ42, a major component of senile plaques, decreases SIRT6 expression, and Aβ42-induced DNA damage is prevented by the overexpression of SIRT6 in HT22 mouse hippocampal neurons. Also, there is a strong negative correlation between Aβ42-induced DNA damage and p53 levels, a protein involved in DNA repair and apoptosis. In addition, upregulation of p53 protein by Nutlin-3 prevents SIRT6 reduction and DNA damage induced by Aβ42. Taken together, this study reveals that p53-dependent SIRT6 expression protects cells from Aβ42-induced DNA damage, making SIRT6 a promising new therapeutic target for the treatment of AD.
Springer Science and Business Media LLC
Title: p53-dependent SIRT6 expression protects Aβ42-induced DNA damage
Description:
AbstractAlzheimer’s disease (AD) is the most common type of dementia and age-related neurodegenerative disease.
Elucidating the cellular changes that occur during ageing is an important step towards understanding the pathogenesis and progression of neurodegenerative disorders.
SIRT6 is a member of the mammalian sirtuin family of anti-aging genes.
However, the relationship between SIRT6 and AD has not yet been elucidated.
Here, we report that SIRT6 protein expression levels are reduced in the brains of both the 5XFAD AD mouse model and AD patients.
Aβ42, a major component of senile plaques, decreases SIRT6 expression, and Aβ42-induced DNA damage is prevented by the overexpression of SIRT6 in HT22 mouse hippocampal neurons.
Also, there is a strong negative correlation between Aβ42-induced DNA damage and p53 levels, a protein involved in DNA repair and apoptosis.
In addition, upregulation of p53 protein by Nutlin-3 prevents SIRT6 reduction and DNA damage induced by Aβ42.
Taken together, this study reveals that p53-dependent SIRT6 expression protects cells from Aβ42-induced DNA damage, making SIRT6 a promising new therapeutic target for the treatment of AD.
Related Results
Abstract 1590: Expression and function of Sirt6 in muscle invasive bladder cancer
Abstract 1590: Expression and function of Sirt6 in muscle invasive bladder cancer
Abstract
Unlike most other solid tumors, there is limited success of targeted agents in treating metastatic bladder cancer (BC), a lethal disease with a median overa...
Abstract 4364228: The Role of Sirtuin 6 in the Coronary Microvascular Dysfunction in Diabetes and Aging
Abstract 4364228: The Role of Sirtuin 6 in the Coronary Microvascular Dysfunction in Diabetes and Aging
Coronary microcirculation is essential to maintaining normal cardiac function. When the cardiac metabolic demand increases (e.g., exercise or stress), coronary blood flow increases...
Abstract SY20-01: Linking epigenetics, metabolism, and cancer: Lessons from SIRT6
Abstract SY20-01: Linking epigenetics, metabolism, and cancer: Lessons from SIRT6
Abstract
In recent years, chromatin regulators have emerged as key modulators in cancer. These factors could work as both tumor suppressors and oncogenes, providi...
Abstract 3366: The role of glucose metabolism and SIRT6 in skin carcinogenesis
Abstract 3366: The role of glucose metabolism and SIRT6 in skin carcinogenesis
Abstract
Metabolic reprogramming to aerobic glycolysis, as described by Otto Warburg decades ago, has recently emerged as a key event during tumorigenesis. However, ...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Linking Epigenetics, Metabolism and Cancer: Lessons From SIRT6
Linking Epigenetics, Metabolism and Cancer: Lessons From SIRT6
Abstract
In recent years, chromatin regulators have emerged as key modulators in cancer. We discovered that the mammalian histone deacetylase SIRT6 is a key chromati...